Email this article 
Ocular Gene Therapy: Literature Review
Abstract
This literature offers complete information about the advances in gene treatment in the of the eye, inclusive of cornea, conjunctiva, lacrimal gland, and trabecular meshwork. We talked about gene transport systems, collectively with viral and non-viral vectors as exact as gene modifying techniques, generally CRISPR-Cas9, and epigenetic treatments, consisting of antisense and siRNA therapeutics. We moreover furnish a specific assessment of gene treatment has been examined with corresponding outcomes. Disease stipulations embody corneal and conjunctival fibrosis and scarring, corneal epithelial wound healing, corneal graft survival, corneal neovascularization, genetic corneal dystrophies, herpetic keratitis, glaucoma, dry eye disease, and specific ocular surface diseases. Although most of the analyzed consequences on the use and validity of gene treatment at the ocular surface have been offered in vitro or the utilization of animal models, we moreover talked about the on hand human studies. Gene treatment methods are nowadays viewed very promising as rising future remedies of a variety of diseases, and this area is unexpectedly expanding.
Keywords
Full Text:
PDFReferences
REFERENCES
- Anguela, Xavier M., and Katherine A. High. "Entering the modern era of gene therapy." Annual review of medicine 70 (2019): 273-288.
- Wirth, Thomas, Nigel Parker, and Seppo Ylä-Herttuala. "History of gene therapy." Gene 525.2 (2013): 162-169.
- Dunbar, Cynthia E., et al. "Gene therapy comes of age." Science 359.6372 (2018): eaan4672.
- Booth, Claire, et al. "Gene therapy for primary immunodeficiency." Human Molecular Genetics 28.R1 (2019): R15-R23.
- Bennett, Jean, and Albert M. Maguire. "Gene therapy for ocular disease." Molecular Therapy 1.6 (2000): 501-505.
- Borrás, Teresa. "Recent developments in ocular gene therapy." Experimental eye research 76.6 (2003): 643-652.
- Di Iorio, Enzo, et al. "New frontiers of corneal gene therapy." Human Gene Therapy 30.8 (2019): 923-945.
- Ljubimov, Alexander V. "Overview of gene therapy in anterior segment." Investigative Ophthalmology & Visual Science 60.9 (2019): 1037-1037.
- Mohan, Rajiv R., Lynn M. Martin, and Nishant R. Sinha. "Novel insights into gene therapy in the cornea." Experimental eye research 202 (2021): 108361.
- Shirley, Jamie L., et al. "Immune responses to viral gene therapy vectors." Molecular Therapy 28.3 (2020): 709-722.
- Volpers, Christoph, and Stefan Kochanek. "Adenoviral vectors for gene transfer and therapy." The Journal of Gene Medicine: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications 6.S1 (2004): S164-S171.
- Mohan, Rajiv R., Jason T. Rodier, and Ajay Sharma. "Corneal gene therapy: basic science and translational perspective." The ocular surface 11.3 (2013): 150-164.
- Saghizadeh, Mehrnoosh, et al. "Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene." Investigative ophthalmology & visual science 51.4 (2010): 1970-1980.
- Lai, Chooi-May, et al. "Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization." Human gene therapy 12.10 (2001): 1299-1310.
- Kaufmann, Claude, et al. "Interleukin-10 gene transfer in rat limbal transplantation." Current eye research 42.11 (2017): 1426-1434.
- Bessis, N., F. J. GarciaCozar, and M. C. Boissier. "Immune responses to gene therapy vectors: influence on vector function and effector mechanisms." Gene therapy 11.1 (2004): S10-S17.
- Kochanek, Stefan. "High-capacity adenoviral vectors for gene transfer and somatic gene therapy." Human gene therapy10.15 (1999): 2451-2459.
- Boutin, Sylvie, et al. "Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors." Human gene therapy21.6 (2010): 704-712.
- Hareendran, Sangeetha, et al. "Adeno‐associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them." Reviews in medical virology 23.6 (2013): 399-413.
- Mingozzi, Federico, and Katherine A. High. "Immune responses to AAV vectors: overcoming barriers to successful gene therapy." Blood, The Journal of the American Society of Hematology 122.1 (2013): 23-36.
- Martino, Ashley T., and David M. Markusic. "Immune response mechanisms against AAV vectors in animal models." Molecular Therapy-Methods & Clinical Development 17 (2020): 198-208.
- Naso, Michael F., et al. "Adeno-associated virus (AAV) as a vector for gene therapy." BioDrugs 31.4 (2017): 317-334.
- Mohan, Rajiv R., et al. "Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo." PloS one 6.10 (2011): e26432.
- Sharma, Ajay, et al. "Polyethylenimine-conjugated gold nanoparticles: Gene transfer potential and low toxicity in the cornea." Nanomedicine: Nanotechnology, Biology and Medicine 7.4 (2011): 505-513.
- Liu, J., et al. "Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy." Molecular Vision 14 (2008): 2087.
- Song, Liujiang, et al. "Serotype survey of AAV gene delivery via subconjunctival injection in mice." Gene Therapy 25.6 (2018): 402-414.
- Bastola, Prabhakar, et al. "Adeno-associated virus mediated gene therapy for corneal diseases." Pharmaceutics 12.8 (2020): 767.
- Tarallo, Valeria, et al. "Inhibition of choroidal and corneal pathological neovascularization by Plgf1-de gene transfer." Investigative Ophthalmology & Visual Science 53.13 (2012): 7989-7996.
- Saint-Geniez, Mali, et al. "Endogenous VEGF is required for visual function: evidence for a survival role on Müller cells and photoreceptors." PloS one 3.11 (2008): e3554.
- Lu, Yi, et al. "Transcriptome profiling of neovascularized corneas reveals miR-204 as a multi-target biotherapy deliverable by rAAVs." Molecular Therapy-Nucleic Acids 10 (2018): 349-360.
- Hirsch, Matthew L., et al. "AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis." Scientific Reports 7.1 (2017): 17840.
- Parker, Douglas GA, et al. "The potential of viral vector-mediated gene transfer to prolong corneal allograft survival." Current gene therapy 9.1 (2009): 33-44.
- Vance, Melisa, et al. "AAV gene therapy for MPS1-associated corneal blindness." Scientific reports 6.1 (2016): 22131.
- Gupta, Suneel, et al. "Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo." PLoS One 12.3 (2017): e0172928.
- Zhou, Lianhong, et al. "Effect of recombinant adeno-associated virus mediated transforming growth factor-beta1 on corneal allograft survival after high-risk penetrating keratoplasty." Transplant Immunology 28.4 (2013): 164-169.
- Alvarez-Rivera, Fernando, et al. "Controlled release of rAAV vectors from APMA-functionalized contact lenses for corneal gene therapy." Pharmaceutics 12.4 (2020): 335.
- Cockrell, Adam S., and Tal Kafri. "Gene delivery by lentivirus vectors." Molecular biotechnology 36 (2007): 184-204.
- Sakuma, Toshie, Michael A. Barry, and Yasuhiro Ikeda. "Lentiviral vectors: basic to translational." Biochemical Journal 443.3 (2012): 603-618.
- Parker, Maria, et al. "Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin." Human Gene Therapy 25.5 (2014): 408-418.
- Wang, Ti, et al. "Inhibition of corneal fibrosis by Smad7 in rats after photorefractive keratectomy." Chinese medical journal 126.08 (2013): 1445-1450.
- Moreira, Pedro Bertino, et al. "Limbal transplantation at a tertiary hospital in Brazil: a retrospective study." Arquivos Brasileiros DE Oftalmologia 78 (2015): 207-211.
- Ramamoorth, Murali, and Aparna Narvekar. "Non viral vectors in gene therapy-an overview." Journal of clinical and diagnostic research: JCDR 9.1 (2015): GE01.
- Hardee, Cinnamon L., et al. "Advances in non-viral DNA vectors for gene therapy." Genes 8.2 (2017): 65.
- Kampik, D., R. R. Ali, and D. F. P. Larkin. "Experimental gene transfer to the corneal endothelium." Experimental eye research 95.1 (2012): 54-59.
- Reyes-Sandoval, Arturo, and Hildegund CJ Ertl. "CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses." Molecular Therapy 9.2 (2004): 249-261.
-Krieg, Arthur M., et al. "Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs." Proceedings of the National Academy of Sciences 95.21 (1998): 12631-12636.
- Yew, Nelson S., et al. "Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs." Molecular therapy 1.3 (2000): 255-262.
- de Wolf, Holger K., et al. "Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes." Pharmaceutical research 25 (2008): 1654-1662.
- Lee, Handule, and Kwangsik Park. "In vitro cytotoxicity of zinc oxide nanoparticles in cultured statens seruminstitut rabbit cornea cells." Toxicological Research 35 (2019): 287-294.
- Tandon, Ashish, et al. "BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo." PloS one 8.6 (2013): e66434.
- Masse, Florence, et al. "Synthesis of ultrastable gold nanoparticles as a new drug delivery system." Molecules 24.16 (2019): 2929.
- Tartaj, Pedro, et al. "The preparation of magnetic nanoparticles for applications in biomedicine." Journal of physics D: Applied physics 36.13 (2003): R182.
- Cornell, Lauren E., et al. "Magnetic nanoparticles as a potential vehicle for corneal endothelium repair." Military medicine 181.suppl_5 (2016): 232-239.
- Xia, Xin, et al. "Magnetic human corneal endothelial cell transplant: delivery, retention, and short-term efficacy." Investigative Ophthalmology & Visual Science 60.7 (2019): 2438-2448.
- Moysidis, Stavros N., et al. "Magnetic field-guided cell delivery with nanoparticle-loaded human corneal endothelial cells." Nanomedicine: Nanotechnology, Biology and Medicine 11.3 (2015): 499-509.
- Tong, Yaw‐Chong, et al. "Eye drop delivery of nano‐polymeric micelle formulated genes with cornea‐specific promoters." The Journal of Gene Medicine: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications 9.11 (2007): 956-966.
- Cholkar, Kishore, et al. "Optimization of dexamethasone mixed nanomicellar formulation." AAPS PharmSciTech 15 (2014): 1454-1467.
- de Redín, Inés Luis, et al. "In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization." Experimental Eye Research 185 (2019): 107697.
- Jiang, Min, et al. "Cationic core–shell liponanoparticles for ocular gene delivery." Biomaterials 33.30 (2012): 7621-7630.
- Ljubimova, Julia Y., et al. "Covalent nano delivery systems for selective imaging and treatment of brain tumors." Advanced drug delivery reviews 113 (2017): 177-200.
- Kopeček, Jindřich, and Jiyuan Yang. "Polymer nanomedicines." Advanced drug delivery reviews 156 (2020): 40-64.
- Tong, Yaw-Chong, et al. "Polymeric micelle gene delivery of bcl-xL via eye drop reduced corneal apoptosis following epithelial debridement." Journal of Controlled Release 147.1 (2010): 76-83.
- Kalomiraki, Marina, Kyriaki Thermos, and Nikos A. Chaniotakis. "Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications." International journal of nanomedicine (2016): 1-12.
- Holden, Christopher A., et al. "Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs." Nanomedicine: nanotechnology, biology and medicine 8.5 (2012): 776-783.
- Soiberman, Uri, et al. "Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation." Biomaterials 125 (2017): 38-53.
- Yang, Xiucheng, et al. "A novel dendrimer-based complex co-modified with cyclic RGD hexapeptide and penetratin for noninvasive targeting and penetration of the ocular posterior segment." Drug Delivery 26.1 (2019): 989-1001.
- Maloy, Stanley, and Kelly Hughes, eds. Brenner's encyclopedia of genetics. Academic Press, 2013.
- Kim, Bumseok, et al. "Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects." The Journal of Immunology 175.1 (2005): 509-516.
- Jani, Pooja D., et al. "Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis." Investigative ophthalmology & visual science 48.5 (2007): 2030-2036.
- Galiacy, S. D., et al. "Matrix metalloproteinase 14 overexpression reduces corneal scarring." Gene therapy 18.5 (2011): 462-468.
- He, Zhiguo, et al. "Ex vivo gene electrotransfer to the endothelium of organ cultured human corneas." Ophthalmic research 43.1 (2009): 43-55.
- Blair‐Parks, Kathleen, Bonnie C. Weston, and David A. Dean. "High‐level gene transfer to the cornea using electroporation." The Journal of Gene Medicine: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications 4.1 (2002): 92-100.
- Rosazza, Christelle, et al. "Gene electrotransfer: a mechanistic perspective." Current gene therapy 16.2 (2016): 98-129.
- Yu, Wen-Zhen, et al. "Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization." Ophthalmic research 35.5 (2003): 239-246.
- Wells, D. J. "Gene therapy progress and prospects: electroporation and other physical methods." Gene therapy 11.18 (2004): 1363-1369.
- Liu, Siyin, et al. "Gene-based antiangiogenic applications for corneal neovascularization." Survey of ophthalmology 63.2 (2018): 193-213.
- Berdugo, M., et al. "Delivery of antisense oligonucleotide to the cornea by iontophoresis." Antisense and Nucleic Acid Drug Development 13.2 (2003): 107-114.
- Sekijima, Hidehisa, et al. "Characterization of ocular iontophoretic drug transport of ionic and non-ionic compounds in isolated rabbit cornea and conjunctiva." Biological and Pharmaceutical Bulletin 39.6 (2016): 959-968.
- Vinciguerra, Paolo, et al. "Iontophoresis-assisted corneal collagen cross-linking with epithelial debridement: preliminary results." BioMed Research International 2016 (2016).
- Bouheraoua, Nacim, et al. "Three different protocols of corneal collagen crosslinking in keratoconus: conventional, accelerated and iontophoresis." JoVE (Journal of Visualized Experiments) 105 (2015): e53119.
- Bikbova, Guzel, and Mukharram Bikbov. "Transepithelial corneal collagen cross‐linking by iontophoresis of riboflavin." Acta ophthalmologica 92.1 (2014): e30-e34.
- Zhang, Er-Ping, et al. "Minimizing side effects of ballistic gene transfer into the murine corneal epithelium." Graefe's archive for clinical and experimental ophthalmology 240 (2002): 114-119.
- Zhang, Er-Ping, et al. "Minimizing side effects of ballistic gene transfer into the murine corneal epithelium." Graefe's archive for clinical and experimental ophthalmology 240 (2002): 114-119.
- Zagon, Ian S., et al. "Particle-mediated gene transfer of opioid growth factor receptor cDNA regulates cell proliferation of the corneal epithelium." Cornea 24.5 (2005): 614-619.
- SA, König Merediz, et al. "Ballistic transfer of minimalistic immunologically defined expression constructs for IL4 and CTLA4 into the corneal epithelium in mice after orthotopic corneal allograft transplantation." Graefe's Archive for Clinical and Experimental Ophthalmology= Albrecht von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie 238.8 (2000): 701-707.
- Müller, Anja, et al. "Influence of ballistic gene transfer on antigen-presenting cells in murine corneas." Graefe's archive for clinical and experimental ophthalmology 240 (2002): 851-859.
- Mohan, Rajiv R., et al. "Gene therapy in the cornea." Progress in retinal and eye research 24.5 (2005): 537-559.
- Mohan, Rajiv R., et al. "Gene therapy in the cornea: 2005–present." Progress in retinal and eye research 31.1 (2012): 43-64.
- Bemelmans, A. P., Y. Arsenijevic, and F. Majo. "Efficient lentiviral gene transfer into corneal stroma cells using a femtosecond laser." Gene therapy 16.7 (2009): 933-938.
- Jumelle, Clotilde, et al. "Delivery of macromolecules into the endothelium of whole ex vivo human cornea by femtosecond laser-activated carbon nanoparticles." British Journal of Ophthalmology 100.8 (2016): 1151-1156.
- Toropainen, Elisa, et al. "Corneal epithelium as a platform for secretion of transgene products after transfection with liposomal gene eyedrops." The Journal of Gene Medicine: A cross‐disciplinary journal for research on the science of gene transfer and its clinical applications 9.3 (2007): 208-216.
- Dannowski, Haike, et al. "Lipid-mediated gene transfer of acidic fibroblast growth factor into human corneal endothelial cells." Experimental eye research 80.1 (2005): 93-101.
- Rossi, Andrea, et al. "Genetic compensation induced by deleterious mutations but not gene knockdowns." Nature 524.7564 (2015): 230-233.
- Scoles, D. R., E. V. Minikel, and S. M. Pulst. "Antisense oligonucleotides: A primer. Neurol Genet 5: e323." (2019).
- Cursiefen, Claus, et al. "Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study." Ophthalmology 121.9 (2014): 1683-1692.
- Cursiefen, Claus, et al. "Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study." Ophthalmology 121.9 (2014): 1683-1692.
- Wasmuth, Susanne, et al. "Topical treatment with antisense oligonucleotides targeting tumor necrosis factor-α in herpetic stromal keratitis." Investigative ophthalmology & visual science 44.12 (2003): 5228-5234.
- Elbadawy, Hossein Mostafa, et al. "Targeting herpetic keratitis by gene therapy." Journal of ophthalmology 2012 (2012).
- Hu, Jiaxin, et al. "Oligonucleotides targeting TCF4 triplet repeat expansion inhibit RNA foci and mis-splicing in Fuchs’ dystrophy." Human molecular genetics 27.6 (2018): 1015-1026.
- Kramerov, Andrei A., et al. "Novel nanopolymer RNA therapeutics normalize human diabetic corneal wound healing and epithelial stem cells." Nanomedicine: Nanotechnology, Biology and Medicine 32 (2021): 102332.
- Zarouchlioti, Christina, et al. "Antisense therapy for a common corneal dystrophy ameliorates TCF4 repeat expansion-mediated toxicity." The American Journal of Human Genetics 102.4 (2018): 528-539.
- Gibson, Daniel J., Sonal S. Tuli, and Gregory S. Schultz. "Dual-phase iontophoresis for the delivery of antisense oligonucleotides." nucleic acid therapeutics 27.4 (2017): 238-250.
- Chau, Viet Q., et al. "Delivery of antisense oligonucleotides to the cornea." nucleic acid therapeutics 30.4 (2020): 207-214.
- Supe, Shibani, Archana Upadhya, and Kavita Singh. "Role of small interfering RNA (siRNA) in targeting ocular neovascularization: a review." Experimental Eye Research 202 (2021): 108329.
- Liu, Q., et al. "siRNA silencing of gene expression in trabecular meshwork: RhoA siRNA reduces IOP in mice." Current Molecular Medicine 12.8 (2012): 1015-1027.
- Courtney, David G., et al. "siRNA silencing of the mutant keratin 12 allele in corneal limbal epithelial cells grown from patients with Meesmann's epithelial corneal dystrophy." Investigative ophthalmology & visual science 55.5 (2014): 3352-3360.
- Qin, Qin, et al. "Effects of CD25siRNA gene transfer on high-risk rat corneal graft rejection." Graefe's Archive for Clinical and Experimental Ophthalmology 253 (2015): 1765-1776.
- Guzman‐Aranguez, A., P. Loma, and J. Pintor. "Small‐interfering RNA s (siRNA s) as a promising tool for ocular therapy." British journal of pharmacology 170.4 (2013): 730-747.
- Saghizadeh, Mehrnoosh, et al. "Enhanced wound healing, kinase and stem cell marker expression in diabetic organ-cultured human corneas upon MMP-10 and cathepsin F gene silencing." Investigative ophthalmology & visual science 54.13 (2013): 8172-8180.
- Saghizadeh, Mehrnoosh, et al. "Normalization of wound healing and stem cell marker patterns in organ-cultured human diabetic corneas by gene therapy of limbal cells." Experimental eye research 129 (2014): 66-73.
- Schiroli, Davide, et al. "Effective in vivo topical delivery of siRNA and gene silencing in intact corneal epithelium using a modified cell-penetrating peptide." Molecular Therapy-Nucleic Acids 17 (2019): 891-906.
- Baran-Rachwalska, Paulina, et al. "Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticles." Journal of Controlled Release 326 (2020): 192-202.
- Yu, Wenhan, and Zhijian Wu. "Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases." Advanced drug delivery reviews 168 (2021): 181-195.
- Wu, Zhijian, Hongyan Yang, and Peter Colosi. "Effect of genome size on AAV vector packaging." Molecular Therapy 18.1 (2010): 80-86.
- Suzuki, Takayuki, et al. "Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome." Virus research 158.1-2 (2011): 154-160.
- Balaggan, K. S., and R. R. Ali. "Ocular gene delivery using lentiviral vectors." Gene therapy 19.2 (2012): 145-153.
- Yang, Yang, et al. "A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice." Nature biotechnology 34.3 (2016): 334-338.
- Jain, Ankur, et al. "CRISPR-Cas9–based treatment of myocilin-associated glaucoma." Proceedings of the National Academy of Sciences 114.42 (2017): 11199-11204.
- Holmgaard, Andreas, et al. "In vivo knockout of the Vegfa gene by lentiviral delivery of CRISPR/Cas9 in mouse retinal pigment epithelium cells." Molecular Therapy-Nucleic Acids 9 (2017): 89-99.
- Lai, Yi, Yongping Yue, and Dongsheng Duan. "Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome≥ 8.2 kb." Molecular Therapy 18.1 (2010): 75-79.
- Wang, Sui, et al. "A gene regulatory network controls the binary fate decision of rod and bipolar cells in the vertebrate retina." Developmental cell 30.5 (2014): 513-527.
- Bakondi, Benjamin, et al. "In vivo CRISPR/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa." Molecular Therapy 24.3 (2016): 556-563.
- Chen, Guojun, et al. "A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing." Nature nanotechnology 14.10 (2019): 974-980.
- Wang, Yuyuan, et al. "A pH-responsive silica–metal–organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries." Journal of Controlled Release 324 (2020): 194-203.
- Chacon-Camacho, Oscar Francisco, and Juan Carlos Zenteno. "Review and update on the molecular basis of Leber congenital amaurosis." World Journal of Clinical Cases: WJCC 3.2 (2015): 112.
- Pennesi, Mark E., et al. "Residual electroretinograms in young Leber congenital amaurosis patients with mutations of AIPL1." Investigative ophthalmology & visual science 52.11 (2011): 8166-8173.
- Gao, Jie, Rehan M. Hussain, and Christina Y. Weng. "Voretigene neparvovec in retinal diseases: a review of the current clinical evidence." Clinical Ophthalmology (2020): 3855-3869.
- Jacobson, Samuel G., et al. "Gene therapy for leber congenital amaurosis caused by RPE65 mutations: safety and efficacy in 15 children and adults followed up to 3 years." Archives of ophthalmology 130.1 (2012): 9-24.
- Weleber, Richard G., et al. "Results at 2 years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood–onset retinal dystrophy." Ophthalmology 123.7 (2016): 1606-1620.
- Chung, Daniel C., et al. "Novel mobility test to assess functional vision in patients with inherited retinal dystrophies." Clinical & experimental ophthalmology 46.3 (2018): 247-259.
- Bennett, Jean, et al. "Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial." The Lancet 388.10045 (2016): 661-672.
- Bainbridge, James WB, et al. "Long-term effect of gene therapy on Leber’s congenital amaurosis." New England Journal of Medicine 372.20 (2015): 1887-1897.
- Russell, Stephen, et al. "Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial." The Lancet 390.10097 (2017): 849-860.
- Grishanin, Ruslan, et al. "Preclinical evaluation of ADVM-022, a novel gene therapy approach to treating wet age-related macular degeneration." Molecular Therapy 27.1 (2019): 118-129.
- Kiss, Szilárd, et al. "Long-term safety evaluation of continuous intraocular delivery of aflibercept by the intravitreal gene therapy candidate ADVM-022 in nonhuman primates." Translational vision science & technology 10.1 (2021): 34-34.
- Gelfman, Claire M., et al. "Comprehensive preclinical assessment of ADVM-022, an intravitreal anti-VEGF gene therapy for the treatment of neovascular AMD and diabetic macular edema." Journal of Ocular Pharmacology and Therapeutics 37.3 (2021): 181-190.
- Kiss, Szilard, et al. "ADVM-022 Intravitreal Gene Therapy for Neovascular AMD-Results from the Phase 1 OPTIC Study." MOLECULAR THERAPY. Vol. 29. No. 4. 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA: CELL PRESS, 2021.
- Khanani, Arshad M., et al. "Phase 1 study of intravitreal gene therapy ADVM-022 for neovascular AMD (OPTIC Trial)." Investigative Ophthalmology & Visual Science 61.7 (2020): 1154-1154.
- Busbee, Brandon, et al. "Phase 1 study of intravitreal gene therapy with ADVM-022 for neovascular AMD (OPTIC Trial)." Investigative Ophthalmology & Visual Science 62.8 (2021): 352-352.
- Kiss, Szilárd, et al. "Analysis of aflibercept expression in NHPs following intravitreal administration of ADVM-022, a potential gene therapy for nAMD." Molecular Therapy-Methods & Clinical Development 18 (2020): 345-353.
- Khanani, Arshad M., et al. "Review of gene therapies for age-related macular degeneration." Eye 36.2 (2022): 303-311.
- Siddiqui, F., A. Aziz, and A. M. Khanani. "Gene therapy for neovascular AMD." Retin. Physician 17 (2020): 36-39.
- Giudice, Giuseppe Lo, Alessandro Galan, and Irene Gattazzo. "Introductory Chapter: Treatment of Medical Retinal Diseases by Surgical Approaches–Mini-Review of the Latest Advances in the Field of Ophthalmology." Medical and Surgical Retina-Recent Innovation, New Perspective, and Applications (2023).
- Khanani, Arshad M., et al. "Review of gene therapies for age-related macular degeneration." Eye 36.2 (2022): 303-311.
- Nozaki, Miho, et al. "Drusen complement components C3a and C5a promote choroidal neovascularization." Proceedings of the National Academy of Sciences 103.7 (2006): 2328-2333.
- Dreismann, Anna K., et al. "Functional expression of complement factor I following AAV-mediated gene delivery in the retina of mice and human cells." Gene Therapy 28.5 (2021): 265-276.
- Waheed, N. K. "FOCUS interim results: GT005 gene therapy phase I/II study for the treatment of geographic atrophy." Angiogenesis, Exudation, and Degeneration (2021).
- Tan, Li Xuan, Kimberly A. Toops, and Aparna Lakkaraju. "Protective responses to sublytic complement in the retinal pigment epithelium." Proceedings of the National Academy of Sciences 113.31 (2016): 8789-8794.
-Khanani, Arshad M., et al. "Review of gene therapies for age-related macular degeneration." Eye 36.2 (2022): 303-311.
- Biosciences, Hemera. "Treatment of advanced dry age related macular degeneration with AAVCAGsCD59. ClinicalTrials. gov." (2020).
- Shah, Anjali R., et al. "Predictors of response to intravitreal anti–vascular endothelial growth factor treatment of age-related macular degeneration." American journal of ophthalmology 163 (2016): 154-166.
- Gaudana, Ripal, et al. "Ocular drug delivery." The AAPS journal 12 (2010): 348-360.
- Yellepeddi, Venkata Kashyap, and Srinath Palakurthi. "Recent advances in topical ocular drug delivery." Journal of Ocular Pharmacology and Therapeutics 32.2 (2016): 67-82.
- Joseph, Rini Rachel, and Subbu S. Venkatraman. "Drug delivery to the eye: what benefits do nanocarriers offer?." Nanomedicine 12.6 (2017): 683-702.
- Gote, Vrinda, et al. "Ocular drug delivery: present innovations and future challenges." Journal of Pharmacology and Experimental Therapeutics 370.3 (2019): 602-624.
- Rafiei, Fojan, Hadi Tabesh, and Farrokh Farzad. "Sustained subconjunctival drug delivery systems: Current trends and future perspectives." International Ophthalmology 40 (2020): 2385-2401.
- Barar, Jaleh, Ali Reza Javadzadeh, and Yadollah Omidi. "Ocular novel drug delivery: impacts of membranes and barriers." Expert opinion on drug delivery 5.5 (2008): 567-581.
- Bourne, Rupert RA, et al. "Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis." The Lancet Global Health 5.9 (2017): e888-e897.
- World Health Organization. "Visual impairment and blindness." Fact sheet 282 (2009).
- Lovicu, Frank, and Daisy Shu. "Myofibroblast transdifferentiation: The dark force in ocular wound healing and fibrosis." (2017).
- Hinz, Boris. "Myofibroblasts." Experimental eye research 142 (2016): 56-70.
- Mohan, Rajiv R., et al. "Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts." Experimental eye research 91.2 (2010): 238-245.
- Schaefer, Liliana, and Renato V. Iozzo. "Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction." Journal of Biological Chemistry 283.31 (2008): 21305-21309.
- Yamaguchi, Yu, David M. Mann, and Erkki Ruoslahti. "Negative regulation of transforming growth factor-β by the proteoglycan decorin." Nature 346.6281 (1990): 281-284.
- Harper, J. R., et al. "[12] Role of transforming growth factor β and decorin in controlling fibrosis." Methods in Enzymology. Vol. 245. Academic Press, 1994. 241-254.
-Huijun, Wang, et al. "Ex vivo transfer of the decorin gene into rat glomerulus via a mesangial cell vector suppressed extracellular matrix accumulation in experimental glomerulonephritis." Experimental and molecular pathology 78.1 (2005): 17-24.
- Donnelly, Kevin S., et al. "Decorin‐PEI nanoconstruct attenuates equine corneal fibroblast differentiation." Veterinary ophthalmology 17.3 (2014): 162-169.
- Sharma, Ajay, et al. "Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer." Molecular Vision 18 (2012): 2598.
- Wang, Shinong, and Raimund Hirschberg. "BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells." American Journal of Physiology-Renal Physiology 284.5 (2003): F1006-F1013.
- Wang, Shinong, and Raimund Hirschberg. "Bone morphogenetic protein-7 signals opposing transforming growth factor β in mesangial cells." Journal of Biological Chemistry 279.22 (2004): 23200-23206.
- Nakao, Atsuhito, et al. "Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling." Nature 389.6651 (1997): 631-635.
- Saika, Shizuya, et al. "Therapeutic effects of adenoviral gene transfer of bone morphogenic protein-7 on a corneal alkali injury model in mice." Laboratory Investigation 85.4 (2005): 474-486.
- Gupta, Suneel, et al. "Novel combination BMP7 and HGF gene therapy instigates selective myofibroblast apoptosis and reduces corneal haze in vivo." Investigative ophthalmology & visual science 59.2 (2018): 1045-1057.
- Cordeiro, M. Francesca, et al. "Transforming growth factor-β1,-β2, and-β3 in vivo: effects on normal and mitomycin c–modulated conjunctival scarring." Investigative ophthalmology & visual science 40.9 (1999): 1975-1982.
- Cordeiro, M. F., et al. "Novel antisense oligonucleotides targeting TGF-β inhibit in vivo scarring and improve surgical outcome." Gene therapy 10.1 (2003): 59-71.
- Chun, Yong Yao, et al. "Positive-charge tuned gelatin hydrogel-siSPARC injectable for siRNA anti-scarring therapy in post glaucoma filtration surgery." Scientific Reports 11.1 (2021): 1470.
- Saika, Shizuya, et al. "Effect of overexpression of pparγ on the healing process of corneal alkali burn in mice." American Journal of Physiology-Cell Physiology 293.1 (2007): C75-C86.
- Behrens, Ashley, et al. "Retroviral gene therapy vectors for prevention of excimer laser-induced corneal haze." Investigative ophthalmology & visual science 43.4 (2002): 968-977.
- Kramerov, Andrei A., et al. "Novel nanopolymer RNA therapeutics normalize human diabetic corneal wound healing and epithelial stem cells." Nanomedicine: Nanotechnology, Biology and Medicine 32 (2021): 102332.
- Saghizadeh, Mehrnoosh, et al. "Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations." The American journal of pathology 158.2 (2001): 723-734.
- Saghizadeh, Mehrnoosh, et al. "Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas." Investigative ophthalmology & visual science 46.10 (2005): 3604-3615.
- Chmielowiec, Jolanta, et al. "c-Met is essential for wound healing in the skin." The Journal of cell biology 177.1 (2007): 151-162.
- Kramerov, Andrei A., Mehrnoosh Saghizadeh, and Alexander V. Ljubimov. "Adenoviral gene therapy for diabetic keratopathy: effects on wound healing and stem cell marker expression in human organ-cultured corneas and limbal epithelial cells." JoVE (Journal of Visualized Experiments) 110 (2016): e54058.
- Sassani, Joseph W., Patricia J. Mc Laughlin, and Ian S. Zagon. "The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes—The Lorenz E. Zimmerman Tribute Lecture." Journal of diabetes research 2016 (2016).
- Funari, Vincent A., et al. "Differentially expressed wound healing-related microRNAs in the human diabetic cornea." PloS one 8.12 (2013): e84425.
- Winkler, Michael A., et al. "Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas." PloS one 9.12 (2014): e114692.
- Wang, Feng, et al. "MiRNA-155-5p reduces corneal epithelial permeability by remodeling epithelial tight junctions during corneal wound healing." Current Eye Research 45.8 (2020): 904-913.
- Niederkorn, Jerry Y. "Immune privilege of corneal allografts." Cornea and External Eye Disease: Corneal Allotransplantation, Allergic Disease and Trachoma (2010): 1-12.
-Pleyer, Uwe, and Stephan Schlickeiser. "The taming of the shrew? The immunology of corneal transplantation." Acta ophthalmologica 87.5 (2009): 488-497.
- Ritter, Thomas, Mieszko Wilk, and Mikhail Nosov. "Gene therapy approaches to prevent corneal graft rejection: where do we stand?." Ophthalmic Research 50.3 (2013): 135-140.
- Williams, Keryn A., Claire F. Jessup, and Douglas J. Coster. "Gene therapy approaches to prolonging corneal allograft survival." Expert opinion on biological therapy 4.7 (2004): 1059-1071.
-Oral, H. B., et al. "Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea." Gene therapy 4.7 (1997): 639-647.
-Comer, Richard M., et al. "Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival." Investigative ophthalmology & visual science 43.4 (2002): 1095-1103.
-Zhou, Shi-you, et al. "Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1." Molecular vision 16 (2010): 1389.
- Hori, Junko, et al. "Immune privilege in corneal transplantation." Progress in retinal and eye research 72 (2019): 100758.
- Amador, Cynthia, et al. "Gene therapy in the anterior eye segment." Current gene therapy 22.2 (2022): 104.
-Verhoeff, Kevin, et al. "Inducible pluripotent stem cells as a potential cure for diabetes." Cells 10.2 (2021): 278.
- Klebe, Sonja, et al. "Prolongation of sheep corneal allograft survival by transfer of the gene encoding ovine IL-12-p40 but not IL-4 to donor corneal endothelium." The Journal of Immunology 175.4 (2005): 2219-2226.
-Salabarria, Ann-Charlott, et al. "Local VEGF-A blockade modulates the microenvironment of the corneal graft bed." American Journal of Transplantation 19.9 (2019): 2446-2456.
-Lu, Xiao-Xiao, and Shao-Zhen Zhao. "Gene-based therapeutic tools in the treatment of cornea disease." Current Gene Therapy 19.1 (2019): 7-19.
- Arsenijevic, Yvan, et al. "Lentiviral vectors for ocular gene therapy." Pharmaceutics 14.8 (2022): 1605.
- Price, Marianne O., et al. "Corneal endothelial dysfunction: Evolving understanding and treatment options." Progress in retinal and eye research 82 (2021): 100904.
- Pastak, Marko, et al. "Gene therapy for modulation of T-cell-mediated immune response provoked by corneal transplantation." Human Gene Therapy 29.4 (2018): 467-479.
- Amador, Cynthia, et al. "Gene therapy in the anterior eye segment." Current gene therapy 22.2 (2022): 104.
- Price, Marianne O., et al. "Corneal endothelial dysfunction: Evolving understanding and treatment options." Progress in retinal and eye research 82 (2021): 100904.
- Maurizi, Eleonora, et al. "Nanoneedles induce targeted siRNA silencing of p16 in the human corneal endothelium." Advanced Science 9.33 (2022): 2203257.
- Arsenijevic, Yvan, et al. "Lentiviral vectors for ocular gene therapy." Pharmaceutics 14.8 (2022): 1605.
- Korecki, Andrea J., et al. "Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells." Gene Therapy 28.6 (2021): 351-372.
- Ruan, Yue, Subao Jiang, and Adrian Gericke. "Age-related macular degeneration: role of oxidative stress and blood vessels." International journal of molecular sciences 22.3 (2021): 1296.
- Kumar, Satheesh, et al. "RNA-targeting strategies as a platform for ocular gene therapy." Progress in Retinal and Eye Research 92 (2023): 101110.
- Han, Haijie, et al. "Polymer-and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives." Advanced Drug Delivery Reviews (2023): 114770.
-Sharif, Zuhair, and Walid Sharif. "Corneal neovascularization: updates on pathophysiology, investigations & management." Romanian journal of ophthalmology 63.1 (2019): 15.
- Hakim, Antoine, et al. "Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: progress towards non-viral systems." Advanced Drug Delivery Reviews (2023): 114781.
- Chowdhury, Ekram Ahmed, et al. "Current progress and limitations of AAV mediated delivery of protein therapeutic genes and the importance of developing quantitative pharmacokinetic/pharmacodynamic (PK/PD) models." Advanced Drug Delivery Reviews 170 (2021): 214-237.
- Deng, Yanhui, et al. "Age-related macular degeneration: Epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy." Genes & diseases 9.1 (2022): 62-79.
- Latifi‐Navid, Hamid, et al. "Network analysis and the impact of Aflibercept on specific mediators of angiogenesis in HUVEC cells." Journal of Cellular and Molecular Medicine 25.17 (2021): 8285-8299.
- Yu, Wenhan, and Zhijian Wu. "Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases." Advanced drug delivery reviews 168 (2021): 181-195.
[218]- Torrecilla Alzola, Josune, et al. "MMP-9 Downregulation with Lipid Nanoparticles for Inhibiting Corneal Neovascularization by Gene Silencing." (2019).
- Liu, Xiaochuan, et al. "SDF-1 Functionalized Hydrogel Microcarriers for skin flap repair." ACS Biomaterials Science & Engineering 8.8 (2022): 3576-3588.
- Catala, Pere, et al. "Approaches for corneal endothelium regenerative medicine." Progress in retinal and eye research 87 (2022): 100987.
- Mohanna, Seyedeh Zeinab Mirjalili, et al. "LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea." Journal of Controlled Release 350 (2022): 401-413.
- Fu, Dun Jack, et al. "Development of a corneal bioluminescence mouse for real-time in vivo evaluation of gene therapies." Translational Vision Science & Technology 9.13 (2020): 44-44.
- Novelli, Flavia, et al. "p63 in corneal and epidermal differentiation." Biochemical and Biophysical Research Communications 610 (2022): 15-22.
- Mohanna, Seyedeh Zeinab Mirjalili, et al. "LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea." Journal of Controlled Release 350 (2022): 401-413.
- Caruso, Salvatore Marco, et al. "CRISPR/Cas therapeutic strategies for autosomal dominant disorders." The Journal of Clinical Investigation 132.9 (2022).
- Wilson, Mark R., et al. "Clusterin, other extracellular chaperones, and eye disease." Progress in Retinal and Eye Research 89 (2022): 101032.
- Sarnicola, Caterina, Asim V. Farooq, and Kathryn Colby. "Fuchs endothelial corneal dystrophy: update on pathogenesis and future directions." Eye & contact lens 45.1 (2019): 1-10.
- Rong, Ziye, et al. "Trinucleotide repeat-targeting dCas9 as a therapeutic strategy for Fuchs’ endothelial corneal dystrophy." Translational Vision Science & Technology 9.9 (2020): 47-47.
- Sawtell, Nancy M., and Richard L. Thompson. "Alphaherpesvirus latency and reactivation with a focus on herpes simplex virus." Current Issues in Molecular Biology 41.1 (2021): 267-356.
- Faria-e-Sousa, Sidney Júlio, and Rosalia Antunes-Foschini. "Herpes simplex keratitis revisited." Arquivos Brasileiros de Oftalmologia 84 (2021): 506-512.
- Abolhosseini, Mohammad, et al. "A triad of microscopes for rapid and proper diagnosis of infectious keratitis." Clinical and Experimental Optometry 105.3 (2022): 333-335.
- Elbadawy, Hossein Mostafa, et al. "Targeting herpetic keratitis by gene therapy." Journal of ophthalmology 2012 (2012).
- Faurez, Florence, et al. "Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection." Vaccine 28.23 (2010): 3888-3895.
- Zhang, Qing, and Fusheng Liu. "Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas." Cell death & disease 11.6 (2020): 485.
- Rathnasinghe, Raveen, et al. "Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1." Scientific Reports 11.1 (2021): 22164.
- Jamali, Arsia, et al. "Characterization of resident corneal plasmacytoid dendritic cells and their pivotal role in herpes simplex keratitis." Cell reports 32.9 (2020).
- Jamali, Arsia, et al. "Characterization of resident corneal plasmacytoid dendritic cells and their pivotal role in herpes simplex keratitis." Cell reports 32.9 (2020).
- Lorentz, Holly, and Heather Sheardown. "Ocular delivery of biopharmaceuticals." Mucosal Delivery of Biopharmaceuticals: Biology, Challenges and Strategies (2014): 221-259.
- Pace, Lanny W. "PRESENT POSITION AND ADDRESS." (2017).
- Marino, Andreana, et al. "Role of herpes simplex envelope glycoprotein B and toll-like receptor 2 in ocular inflammation: an ex vivo organotypic rabbit corneal model." Viruses 11.9 (2019): 819.
- Matundan, Harry, and Homayon Ghiasi. "Herpes simplex virus 1 ICP22 suppresses CD80 expression by murine dendritic cells." Journal of virology 93.3 (2019): e01803-18.
Shoji, Jun, et al. "A diagnostic method for herpes simplex keratitis by simultaneous measurement of viral DNA and virus-specific secretory IgA in tears: an evaluation." Japanese journal of ophthalmology 60 (2016): 294-301.
- Huang, Mengwen, et al. "Mucosal vaccine delivery: A focus on the breakthrough of specific barriers." Acta Pharmaceutica Sinica B (2022).
- Dhanushkodi, Nisha Rajeswari, et al. "Mucosal CCL28 Chemokine Improves Protection against Genital Herpes through Mobilization of Antiviral Effector Memory CCR10+ CD44+ CD62L− CD8+ T Cells and Memory CCR10+ B220+ CD27+ B Cells into the Infected Vaginal Mucosa." The Journal of Immunology (2023).
- Tian, Bo, et al. "Ocular drug delivery: advancements and Innovations." Pharmaceutics 14.9 (2022): 1931.
- Sadeghian, Issa, et al. "Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines." European Journal of Pharmaceutical Sciences 169 (2022): 106094.
- Zhu, Shuyong, and Abel Viejo-Borbolla. "Pathogenesis and virulence of herpes simplex virus." Virulence 12.1 (2021): 2670-2702.
- Villa, Erica, et al. "Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19." Blood advances 5.3 (2021): 662-673.
- Chapellier, Benoit, et al. "Meganuclease targeting HSV-1 protects against herpetic keratitis: Application to corneal transplants." Molecular Therapy-Nucleic Acids 30 (2022): 511-521.
- Harrell, C. Randall, et al. "Therapeutic potential of mesenchymal stem cells and their secretome in the treatment of glaucoma." Stem cells international 2019 (2019).
- Picaud, Serge, et al. "The primate model for understanding and restoring vision." Proceedings of the National Academy of Sciences 116.52 (2019): 26280-26287.
- Becker, Jonas, Julia Fakhiri, and Dirk Grimm. "Fantastic AAV gene therapy vectors and how to find them—random diversification, rational design and machine learning." Pathogens 11.7 (2022): 756.
- Sharif, Najam A. "Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies." Frontiers in pharmacology 12 (2021): 729249.
- van Mechelen, Ralph JS, et al. "Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review." Experimental eye research 217 (2022): 108972.
- Rahić, Ognjenka, et al. "Novel drug delivery systems fighting glaucoma: Formulation obstacles and solutions." Pharmaceutics 13.1 (2020): 28.
- Naik, Santoshi, et al. "Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma: Recent advancements and future perspectives." Life Sciences 264 (2021): 118712.
- Shen, Junhui, Yuanqi Wang, and Ke Yao. "Protection of retinal ganglion cells in glaucoma: Current status and future." Experimental Eye Research 205 (2021): 108506.
Sun, Difang, et al. "Long-term and potent IOP-lowering effect of IκBα-siRNA in a nonhuman primate model of chronic ocular hypertension." Iscience 25.4 (2022): 104149.
- Ng, Si Yun, and Alan Yiu Wah Lee. "Traumatic brain injuries: pathophysiology and potential therapeutic targets." Frontiers in cellular neuroscience 13 (2019): 528.
-Tan, Junkai, et al. "C3 transferase-expressing scAAV2 transduces ocular anterior segment tissues and lowers intraocular pressure in mouse and monkey." Molecular Therapy-Methods & Clinical Development 17 (2020): 143-155.
-Bannier-Hélaouët, Marie, et al. "Exploring the human lacrimal gland using organoids and single-cell sequencing." Cell stem cell 28.7 (2021): 1221-1232.
-Molino, Jay. "Microcápsulas vacías empleadas en aplicaciones de ultrasonidos: generalidades, usos y métodos de fabricación." (2019).
-Bastola, Prabhakar, et al. "Adeno-associated virus mediated gene therapy for corneal diseases." Pharmaceutics 12.8 (2020): 767.
-Singh, Vimal Kishor, et al. "Current approaches for the regeneration and reconstruction of ocular surface in dry eye." Frontiers in Medicine 9 (2022): 885780.
-Yao, Yuan, et al. "Immunobiology of T cells in Sjögren’s syndrome." Clinical Reviews in Allergy & Immunology 60 (2021): 111-131.
-Pflugfelder, Stephen C., and Michael E. Stern. "Biological functions of tear film." Experimental eye research 197 (2020): 108115.
-Alam, Jehan, Cintia S. de Paiva, and Stephen C. Pflugfelder. "Immune-Goblet cell interaction in the conjunctiva." The ocular surface 18.2 (2020): 326-334.
-Xu, Yining, et al. "Surface modification of lipid-based nanoparticles." ACS nano 16.5 (2022): 7168-7196.
-Singh, Neera, et al. "Epithelial barrier dysfunction in ocular allergy." Allergy 77.5 (2022): 1360-1372.
-Nagai, Noriaki, and Hiroko Otake. "Novel drug delivery systems for the management of dry eye." Advanced Drug Delivery Reviews (2022): 114582.
-Shah, Ruchi, et al. "Systemic diseases and the cornea." Experimental eye research 204 (2021): 108455.
-Hampe, Christiane S., et al. "Mucopolysaccharidosis type I: a review of the natural history and molecular pathology." Cells 9.8 (2020): 1838.
-Loret, Amaury, et al. "Joint manifestations revealing inborn metabolic diseases in adults: a narrative review." Orphanet Journal of Rare Diseases 18.1 (2023): 1-11.
-Salman, Mohd, et al. "New frontier in the management of corneal dystrophies: basics, development, and challenges in corneal gene therapy and gene editing." The Asia-Pacific Journal of Ophthalmology 11.4 (2022): 346-359.
-Del Rio, Danila, et al. "CAV-2 vector development and gene transfer in the central and peripheral nervous systems." Frontiers in Molecular Neuroscience 12 (2019): 71.
-D’Oria, F., R. Barraquer, and J. L. Alio. "Crystalline lens alterations in congenital aniridia." Archivos de la Sociedad Española de Oftalmología (English Edition) 96 (2021): 38-51.
-Luboń, Wojciech, et al. "Understanding ocular findings and manifestations of systemic lupus erythematosus: Update review of the literature." International Journal of Molecular Sciences 23.20 (2022): 12264.
-Daruich, Alejandra, et al. "Congenital aniridia beyond black eyes: from phenotype and novel genetic mechanisms to innovative therapeutic approaches." Progress in Retinal and Eye Research (2022): 101133.
-Taha, Eman A., Joseph Lee, and Akitsu Hotta. "Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges." Journal of Controlled Release 342 (2022): 345-361.
-Latta, Lorenz, et al. "Pathophysiology of aniridia-associated keratopathy: Developmental aspects and unanswered questions." The Ocular Surface 22 (2021): 245-266.
DOI: http://dx.doi.org/10.52155/ijpsat.v40.2.5623
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Maged Naser
This work is licensed under a Creative Commons Attribution 4.0 International License.